Login
Navigate Fool.com
Will PRTA beat
the market?

Prothena Corporation (NASDAQ: PRTA)

Community Rating: 1 Star: Ominous

18.22 -0.26 (-1.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $18.27
Previous Close $18.48
Daily Range $17.70 - $18.39
52-Week Range $15.00 - $49.24
Market Cap $399.1M
P/E Ratio -20.31
Dividend (Yield) $0.00 (0.0%)
Volume 216,928
Average Daily Volume 442,379
Current FY EPS -$0.64

How do you think PRTA
will perform against the market?

Top PRTA Bull/Bear Pitches

 

pchop123 (< 20)
Submitted December 12, 2013

momentum likely to continue

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted October 22, 2013

Prothena has a healthy market cap of 450M despite a very immature pipeline and a questionable therapeutic platform. The company purports to treat amyloidosis and Parkinson's disease with monoclonal an … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Why Is Wall Street Gobbling Up These 2 Small-Cap Biotech Stocks?

Wall Street has been snapping up shares of Prothena and Five Prime Therapeutics. Here's why.

3 Biotech Stocks Falling Like a Knife: Aegerion, Insys, and Prothena

When biotechs fall, they can create compelling buying opportunities for the long-term investor. Here is a Foolish look at three biotechs that have dropped in dramatic fashion in the last quarter.

Wednesday Sector Laggards: Music & Electronics Stores, Drugs

Why Prothena Corporation PLC Shares Leaped Higher

Prothena shares jump following an update on the progress of experimental Parkinson's disease drug PRX002. Can its shares head even higher?

3 Warning Signs the Biotech Rally May Be Over

The biotech sector has been creamed over the past couple of sessions. Have you been ignoring these three biotech bubble warning signs?

Why Prothena, Galena Biopharma, and Horizon Pharma Are Today's 3 Best Stocks

The S&P 500 dips following the FOMC meeting, but these three biopharmaceutical stocks all soared!

Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals

Horizon Pharma, Prothena, and Portola Pharmaceuticals could all make health care headlines this morning. Here’s why.

Healthcare Stocks Still In Hole Near Close; Prothera Adds Over 10% After Pricing Secondary Offering

Sector Update: Healthcare

3 Companies Working on Parkinson's Treatments You Ought to Know About

Parkinson's may be tough-to-treat, but Chelsea (CHTP), Avanir (AVNR), and Prothena (PRTA) are hard at work developing new treatments.

See More PRTA News...

Sector

Industry

Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks